13F-HR filed by Squadron Capital Management LLC
Squadron Capital Management LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 33 holding rows worth $235,971,129.
- Accession
- 0002050709-26-000010
- Filer
- CIK 2050709
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 33 entries on the cover page, a total value of $235,971,129 stated on the cover page (in dollars after the unit check, H1), rows summing to $235,971,129 with VALUE read as dollars as filed, 13F file number 028-26573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 6,700,000 | $32,361,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 780,000 | $27,705,600 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 490,000 | $20,300,700 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 145,000 | $19,553,975 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 700,000 | $11,305,000 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 4,500,000 | $10,575,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 350,000 | $8,685,250 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 4,225,000 | $8,661,250 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 291,710 | $8,156,212 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 190,000 | $7,676,000 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 338,000 | $6,800,560 | dollars as filed | call |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 80,000 | $6,550,400 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 230,650 | $6,262,148 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 70,000 | $6,097,700 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 105,551 | $4,730,796 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 240,000 | $4,600,800 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 525,000 | $4,294,500 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 530,000 | $4,255,900 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 26,000 | $4,158,960 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 315,000 | $4,000,500 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 500,000 | $3,775,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 410,000 | $3,702,300 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 236,966 | $3,362,548 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 60,000 | $3,038,400 | dollars as filed | call |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 175,000 | $2,975,000 | dollars as filed | |
| PASITHEA THERAPEUTICS CORP | 70261F202 | COM NEW | 2,100,000 | $2,709,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 388,287 | $2,679,180 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 130,000 | $2,360,800 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 300,000 | $1,395,000 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 36,000 | $1,307,160 | dollars as filed | call |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 713,540 | $806,300 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 81,000 | $728,190 | dollars as filed | call |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 100,000 | $400,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002050709-26-000010 | this filing | 2026-02-17 | acceptance time not in the bulk data set |